LOUISVILLE, Colo., Aug. 7, 2012 /PRNewswire/ -- GHX today announced successful results from its initial implantable device supply chain (IDSC) pilot sites. The company began rolling out the first phase of its pilot program earlier this year with sites including both healthcare provider and manufacturer organizations. Based on its extensive research into implantable device use, GHX believes better management of clinical, operational and financial processes can help increase revenue capture, lower supply chain costs and improve staff productivity to help reduce the estimated $5 billion in annual loss in this market segment, which results from a number of issues including inefficient manual business processes and lost, wasted and expired products.
With the past 12 years dedicated to creating solutions that help automate the medical-surgical supply chain, GHX has worked with both provider and supplier organizations and has unique expertise that can now be applied to the IDSC, leveraging the lessons GHX and its customers have learned as they've worked to drive out billions of dollars of supply chain costs. The first phase of IDSC pilot results confirmed:
"We knew we wanted to be in the early pilot phase," said Randy Hayas, corporate director, Materials Management at Orlando Health. "The value to Orlando Health in improving the implantable device supply chain was too important
'/>"/>
| SOURCE GHX Copyright©2012 PR Newswire. All rights reserved |